Loading company…
Synchroneuron develops therapies for tardive dyskinesia and related movement disorders.
Synchroneuron is a biopharmaceutical company developing therapies for tardive dyskinesia and other related movement disorders.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in